33 research outputs found

    Pathways deployed by human placental trophoblasts to confer viral resistance

    Get PDF
    During pregnancy, the placenta plays a vital role in protecting the developing fetus from microbial infections. The multinucleated and terminally differentiated syncytiotrophoblasts actively coordinate host defense through a multitude of mechanisms. In addition to forming a cellular barrier, the syncytiotrophoblasts release extracellular vesicles containing microRNAs from the chromosome 19 microRNA cluster (C19MC). These vesicle-packaged miRNAs, upon uptake by recipient cells, induce autophagy and limit viral infection, acting against a diverse panel of both DNA and RNA viruses. We have shown that medium conditioned by primary human trophoblast (PHT) cells, which contain these vesicles, confers resistance from pathogens associated with congenital infections to recipient non-placental cells. Furthermore, we have demonstrated that primary human trophoblasts constitutively produce interferon lambda 1 (IFNλ1), leading to a robust induction of interferon stimulated genes in an autocrine and paracrine manner. These parallel pathways, actively coordinated by PHT cells, contribute to the barrier function of the placenta, protecting the developing fetus from viral infections

    Wilavidin* — a novel member of the avidin family that forms unique biotin‐binding hexamers

    No full text
    Nature's optimization of protein functions is a highly intricate evolutionary process. In addition to optimal tertiary folding, the intramolecular recognition among the monomers that generate higher-order quaternary arrangements is driven by stabilizing interactions that have a pivotal role for ideal activity. Homotetrameric avidin and streptavidin are regularly utilized in many applications, whereby their ultra-high affinity toward biotin is dependent on their quaternary arrangements. In recent years, a new subfamily of avidins was discovered that comprises homodimers rather than tetramers, in which the high affinity toward biotin is maintained. Intriguingly, several of the respective dimers have been shown to assemble into higher-order cylindrical hexamers or octamers that dissociate into dimers upon biotin binding. Here, we present wilavidin, a newly discovered member of the dimeric subfamily, forming hexamers in the apo form, which are uniquely maintained upon biotin binding with six high-affinity binding sites. Removal of the short C-terminal segment of wilavidin resulted in the presence of the dimer only, thus emphasizing the role of this segment in stabilizing the hexamer. Utilization of a hexavalent biotin-binding form of avidin would be beneficial for expanding the biotechnological toolbox. Additionally, this unique family of dimeric avidins and their propensity to oligomerize to hexamers or octamers can serve as a basis for protein oligomerization and intermonomeric recognition as well as cumulative interactions that determine molecular assemblies

    Pyk2 inhibition promotes contractile differentiation in arterial smooth muscle

    No full text
    Modulation from contractile to synthetic phenotype of vascular smooth muscle cells is a central process in disorders involving compromised integrity of the vascular wall. Phenotype modulation has been shown to include transition from voltage-dependent toward voltage-independent regulation of the intracellular calcium level, and inhibition of non-voltage dependent calcium influx contributes to maintenance of the contractile phenotype. One possible mediator of calcium-dependent signaling is the FAK-family non-receptor protein kinase Pyk2, which is activated by a number of stimuli in a calcium-dependent manner. We used the Pyk2 inhibitor PF-4594755 and Pyk2 siRNA to investigate the role of Pyk2 in phenotype modulation in rat carotid artery smooth muscle cells and in cultured intact arteries. Pyk2 inhibition promoted the expression of smooth muscle markers at the mRNA and protein levels under stimulation by FBS or PDGF-BB and counteracted phenotype shift in cultured intact carotid arteries and balloon injury ex vivo. During long-term (24–96 hr) treatment with PF-4594755, smooth muscle markers increased before cell proliferation was inhibited, correlating with decreased KLF4 expression and differing from effects of MEK inhibition. The Pyk2 inhibitor reduced Orai1 and preserved SERCA2a expression in carotid artery segments in organ culture, and eliminated the inhibitory effect of PDGF stimulation on L-type calcium channel and large-conductance calcium-activated potassium channel expression in carotid cells. Basal intracellular calcium level, calcium wave activity, and store-operated calcium influx were reduced after Pyk2 inhibition of growth-stimulated cells. Pyk2 inhibition may provide an interesting approach for preserving vascular smooth muscle differentiation under pathophysiological conditions
    corecore